Global Orally Disintegrating Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.

According to APO Research, The global Orally Disintegrating Tablet market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Orally Disintegrating Tablet is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Orally Disintegrating Tablet is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Orally Disintegrating Tablet is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Orally Disintegrating Tablet is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Orally Disintegrating Tablet include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company and AstraZeneca, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Orally Disintegrating Tablet, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Orally Disintegrating Tablet, also provides the sales of main regions and countries. Of the upcoming market potential for Orally Disintegrating Tablet, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Orally Disintegrating Tablet sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Orally Disintegrating Tablet market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Orally Disintegrating Tablet sales, projected growth trends, production technology, application and end-user industry.


Orally Disintegrating Tablet Segment by Company

Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer

Orally Disintegrating Tablet Segment by Type

Anti-Psychotics Drug
Anti-Epileptics Drug
Others

Orally Disintegrating Tablet Segment by Application

CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Others

Orally Disintegrating Tablet Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orally Disintegrating Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Orally Disintegrating Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orally Disintegrating Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Orally Disintegrating Tablet market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Orally Disintegrating Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Orally Disintegrating Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Orally Disintegrating Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Orally Disintegrating Tablet Market Size, 2020 VS 2024 VS 2031
1.3 Global Orally Disintegrating Tablet Market Size Estimates and Forecasts (2020-2031)
1.4 Global Orally Disintegrating Tablet Sales Estimates and Forecasts (2020-2031)
1.5 Global Orally Disintegrating Tablet Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Orally Disintegrating Tablet Market Dynamics
2.1 Orally Disintegrating Tablet Industry Trends
2.2 Orally Disintegrating Tablet Industry Drivers
2.3 Orally Disintegrating Tablet Industry Opportunities and Challenges
2.4 Orally Disintegrating Tablet Industry Restraints
3 Orally Disintegrating Tablet Market by Manufacturers
3.1 Global Orally Disintegrating Tablet Revenue by Manufacturers (2020-2025)
3.2 Global Orally Disintegrating Tablet Sales by Manufacturers (2020-2025)
3.3 Global Orally Disintegrating Tablet Average Sales Price by Manufacturers (2020-2025)
3.4 Global Orally Disintegrating Tablet Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Orally Disintegrating Tablet Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Orally Disintegrating Tablet Manufacturers, Product Type & Application
3.7 Global Orally Disintegrating Tablet Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Orally Disintegrating Tablet Market CR5 and HHI
3.8.2 Global Top 5 and 10 Orally Disintegrating Tablet Players Market Share by Revenue in 2024
3.8.3 2024 Orally Disintegrating Tablet Tier 1, Tier 2, and Tier 3
4 Orally Disintegrating Tablet Market by Type
4.1 Orally Disintegrating Tablet Type Introduction
4.1.1 Anti-Psychotics Drug
4.1.2 Anti-Epileptics Drug
4.1.3 Others
4.2 Global Orally Disintegrating Tablet Sales by Type
4.2.1 Global Orally Disintegrating Tablet Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Orally Disintegrating Tablet Sales by Type (2020-2031)
4.2.3 Global Orally Disintegrating Tablet Sales Market Share by Type (2020-2031)
4.3 Global Orally Disintegrating Tablet Revenue by Type
4.3.1 Global Orally Disintegrating Tablet Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Orally Disintegrating Tablet Revenue by Type (2020-2031)
4.3.3 Global Orally Disintegrating Tablet Revenue Market Share by Type (2020-2031)
5 Orally Disintegrating Tablet Market by Application
5.1 Orally Disintegrating Tablet Application Introduction
5.1.1 CNS Diseases
5.1.2 Gastrointestinal Diseases
5.1.3 CVS Diseases
5.1.4 Others
5.2 Global Orally Disintegrating Tablet Sales by Application
5.2.1 Global Orally Disintegrating Tablet Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Orally Disintegrating Tablet Sales by Application (2020-2031)
5.2.3 Global Orally Disintegrating Tablet Sales Market Share by Application (2020-2031)
5.3 Global Orally Disintegrating Tablet Revenue by Application
5.3.1 Global Orally Disintegrating Tablet Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Orally Disintegrating Tablet Revenue by Application (2020-2031)
5.3.3 Global Orally Disintegrating Tablet Revenue Market Share by Application (2020-2031)
6 Global Orally Disintegrating Tablet Sales by Region
6.1 Global Orally Disintegrating Tablet Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Orally Disintegrating Tablet Sales by Region (2020-2031)
6.2.1 Global Orally Disintegrating Tablet Sales by Region (2020-2025)
6.2.2 Global Orally Disintegrating Tablet Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Orally Disintegrating Tablet Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Orally Disintegrating Tablet Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Orally Disintegrating Tablet Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Orally Disintegrating Tablet Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Orally Disintegrating Tablet Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Orally Disintegrating Tablet Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Orally Disintegrating Tablet Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Orally Disintegrating Tablet Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Orally Disintegrating Tablet Revenue by Region
7.1 Global Orally Disintegrating Tablet Revenue by Region
7.1.1 Global Orally Disintegrating Tablet Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Orally Disintegrating Tablet Revenue by Region (2020-2025)
7.1.3 Global Orally Disintegrating Tablet Revenue by Region (2026-2031)
7.1.4 Global Orally Disintegrating Tablet Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Orally Disintegrating Tablet Revenue (2020-2031)
7.2.2 North America Orally Disintegrating Tablet Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Orally Disintegrating Tablet Revenue (2020-2031)
7.3.2 Europe Orally Disintegrating Tablet Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Orally Disintegrating Tablet Revenue (2020-2031)
7.4.2 Asia-Pacific Orally Disintegrating Tablet Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Orally Disintegrating Tablet Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Orally Disintegrating Tablet Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Teva
8.1.1 Teva Comapny Information
8.1.2 Teva Business Overview
8.1.3 Teva Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Teva Orally Disintegrating Tablet Product Portfolio
8.1.5 Teva Recent Developments
8.2 Merck
8.2.1 Merck Comapny Information
8.2.2 Merck Business Overview
8.2.3 Merck Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Merck Orally Disintegrating Tablet Product Portfolio
8.2.5 Merck Recent Developments
8.3 Mylan
8.3.1 Mylan Comapny Information
8.3.2 Mylan Business Overview
8.3.3 Mylan Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Mylan Orally Disintegrating Tablet Product Portfolio
8.3.5 Mylan Recent Developments
8.4 Pfizer
8.4.1 Pfizer Comapny Information
8.4.2 Pfizer Business Overview
8.4.3 Pfizer Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Pfizer Orally Disintegrating Tablet Product Portfolio
8.4.5 Pfizer Recent Developments
8.5 Johnson and Johnson
8.5.1 Johnson and Johnson Comapny Information
8.5.2 Johnson and Johnson Business Overview
8.5.3 Johnson and Johnson Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Johnson and Johnson Orally Disintegrating Tablet Product Portfolio
8.5.5 Johnson and Johnson Recent Developments
8.6 GSK
8.6.1 GSK Comapny Information
8.6.2 GSK Business Overview
8.6.3 GSK Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 GSK Orally Disintegrating Tablet Product Portfolio
8.6.5 GSK Recent Developments
8.7 Otsuka
8.7.1 Otsuka Comapny Information
8.7.2 Otsuka Business Overview
8.7.3 Otsuka Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Otsuka Orally Disintegrating Tablet Product Portfolio
8.7.5 Otsuka Recent Developments
8.8 Eli Lilly and Company
8.8.1 Eli Lilly and Company Comapny Information
8.8.2 Eli Lilly and Company Business Overview
8.8.3 Eli Lilly and Company Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Eli Lilly and Company Orally Disintegrating Tablet Product Portfolio
8.8.5 Eli Lilly and Company Recent Developments
8.9 AstraZeneca
8.9.1 AstraZeneca Comapny Information
8.9.2 AstraZeneca Business Overview
8.9.3 AstraZeneca Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 AstraZeneca Orally Disintegrating Tablet Product Portfolio
8.9.5 AstraZeneca Recent Developments
8.10 Bristol-Myers Squibb
8.10.1 Bristol-Myers Squibb Comapny Information
8.10.2 Bristol-Myers Squibb Business Overview
8.10.3 Bristol-Myers Squibb Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Bristol-Myers Squibb Orally Disintegrating Tablet Product Portfolio
8.10.5 Bristol-Myers Squibb Recent Developments
8.11 Conquer
8.11.1 Conquer Comapny Information
8.11.2 Conquer Business Overview
8.11.3 Conquer Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Conquer Orally Disintegrating Tablet Product Portfolio
8.11.5 Conquer Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Orally Disintegrating Tablet Value Chain Analysis
9.1.1 Orally Disintegrating Tablet Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Orally Disintegrating Tablet Production Mode & Process
9.2 Orally Disintegrating Tablet Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Orally Disintegrating Tablet Distributors
9.2.3 Orally Disintegrating Tablet Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings